MASS241220P5000
- 0.00
- 0.000.00%
908 Devices Newsroom
Analysts Have Lowered Expectations For 908 Devices Inc. (NASDAQ:MASS) After Its Latest Results
Investors Give 908 Devices Inc. (NASDAQ:MASS) Shares A 33% Hiding
908 Devices Third Quarter 2024 Earnings: Misses Expectations
Take Care Before Jumping Onto 908 Devices Inc. (NASDAQ:MASS) Even Though It's 33% Cheaper
Correction to 908 Devices Rating
908 Devices Is Maintained at Buy by Stifel
TD Cowen Maintains 908 Devices(MASS.US) With Buy Rating
Stifel Maintains 908 Devices(MASS.US) With Buy Rating, Cuts Target Price to $6
Express News | 908 Devices Inc. : Stifel Cuts Target Price to $6 From $17
908 Devices Price Target Announced at $4.00/Share by Leerink Partners
908 Devices Analyst Ratings
Leerink Partners Downgrades 908 Devices(MASS.US) to Hold Rating, Cuts Target Price to $4
Express News | 908 Devices Inc. : Leerink Partners Cuts to Market Perform From Outperform
TD Cowen Initiates 908 Devices(MASS.US) With Buy Rating
TD Cowen Reaffirms Their Buy Rating on 908 Devices (MASS)
908 Devices Inc. (MASS) Q3 2024 Earnings Call Transcript Summary
12 Information Technology Stocks Moving In Tuesday's Pre-Market Session
908 Devices | 8-K: 908 Devices Reports Third Quarter 2024 Financial Results and Updates 2024 Revenue Outlook
908 Devices Restructures for Cost Efficiency and Growth
908 Devices Rationalizing Bioprocessing And Life Science Instrumentation Investments By Completing A Reduction In Force In November Of Approximately 11% To Reduce Operating Expenses Across Sales, Marketing And Research And Development